Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GKL-006 in advanced pancreatic cancer
NCT07777211Phase 2Recruiting
- Sponsor
- GenePlus
- Start
- Aug 2025
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
A Phase 2 trial of GKL-006 in pancreatic ductal adenocarcinoma (PDAC), sponsored by GenePlus. Started Aug 2025; status: recruiting.
02
Drugs
GKL-006
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT07777211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07777211.